1. Home
  2. HTBK vs XNCR Comparison

HTBK vs XNCR Comparison

Compare HTBK & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HTBK

Heritage Commerce Corp

HOLD

Current Price

$13.45

Market Cap

739.7M

Sector

Finance

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$12.85

Market Cap

881.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTBK
XNCR
Founded
1997
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
739.7M
881.9M
IPO Year
1998
2013

Fundamental Metrics

Financial Performance
Metric
HTBK
XNCR
Price
$13.45
$12.85
Analyst Decision
Hold
Buy
Analyst Count
6
10
Target Price
$12.88
$22.33
AVG Volume (30 Days)
682.5K
798.3K
Earning Date
04-24-2026
05-06-2026
Dividend Yield
3.87%
N/A
EPS Growth
18.18
65.36
EPS
0.78
N/A
Revenue
$3,688,000.00
$125,576,000.00
Revenue This Year
$7.80
N/A
Revenue Next Year
$5.51
$4.80
P/E Ratio
$17.24
N/A
Revenue Growth
3.57
13.65
52 Week Low
$8.74
$6.92
52 Week High
$13.83
$18.69

Technical Indicators

Market Signals
Indicator
HTBK
XNCR
Relative Strength Index (RSI) 64.54 56.48
Support Level $11.85 $12.29
Resistance Level $13.65 $12.87
Average True Range (ATR) 0.31 0.72
MACD 0.07 0.07
Stochastic Oscillator 81.90 75.11

Price Performance

Historical Comparison
HTBK
XNCR

About HTBK Heritage Commerce Corp

Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. Majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Share on Social Networks: